The 3rd International Conference for Improving Use of Medicines (ICIUM) was held in Antalya, Turkey, November 14-18, 2011. Below are audio recordings of some sessions attended by João Carapinha.

Opening – Keynote Addresses

From ICIUM 2004 to ICIUM 2011 – Challenges and Opportunities for Medicines Access and Use. Suwit Wibulpolprasert, Ministry of Public Health, Thailand.

1c. Economics: Pricing Tools to Improve Medicines Affordability

Price Information Exchange for Selected Medicines in the World Health Organization Western Pacific Region. Dardane Arifaj-Blumi , World Health Organization Western Pacific Regional Office.

Challenges of Health Care Financing and Access to Medicines in Low-income Countries of Asia. Soonman Kwon , Seoul National University, Korea, South (Republic of)

External Reference Pricing (ERP): Existing Evidence and Lessons for Developing Countries. Jaime Espín, Andalusian School of Public Health, Spain.

A Win-Win Solution? Critical Analysis of Tiered Pricing to Improve Access to Medicines in Developing Countries. Suerie Moon, Medecins Sans Frontieres, Campaign for Access to Essential Medicines, Switzerland.

2c. Economics: Pricing Tools to Improve Medicines Affordability

Efficiency of Public Procurement of Medicines in the Philippines. Klara Tisocki, Health Action International, Consultants for Health and Development, Netherlands.

Can Competition Law or Other Competition-Promoting Policies Reduce Medicine Prices in Developing Countries? Loraine Hawkins, Independent, United Kingdom.

Evolution of Generic Medicine Market Share in the Pharmaceutical Retail Sector of 21 Low- and Middle-Income Countries Between 1999 and 2009: Time-Series Analysis. Warren Kaplan, Center for Global Health and Development, Boston University.

Taxes on Medicines. Margaret Ewen, Health Action International, Amsterdam.

Plenary 3: Health Care and Financing Institutions

Win-Win or Lose-Lose? Improving Use of Medicines – Why a Multi-Stakeholder Approach to Increasing Access to Medicines is Needed. Saul Sebastian Walker, Department for International Development, United Kingdom.

A System Framework for Access to Medicines – Implications for Research and Policy. Maryam Bigdeli, Alliance for Health Policy and Systems Research, World Health Organization, Switzerland.

Universal Health Coverage and Access to Medicines: Golden Ring or Trojan Horse? Jonathan Dickinson Quick, Management Sciences for Health, United States of America.

Plenary 5: Consumers, Patients, and Community Systems.

Health Care and Medicines Need and Access – Are There Gender Inequities? Anita Katharina Wagner, Harvard Medical School, United States of America.

Methods 3: Indicators of Pharmaceutical Industry Performance in Improving Medicines Situations in LMIC – How to Focus on Medicines Use?

ATMI Overview. Afshin Mehrpouya, HEC-Paris, France.

The ATM Index – R&D Pharma Industry Perspective. Jeff Kemprecos, MSD International GmbH, Switzerland.

The ATM Index – Academia Perspective. Göran Bengt Tomson, Karolinska Institutet, Sweden.

The ATM Index – International Organizations Perspective. Andreas Seiter, World Bank, United States of America.

The ATM Index – NGO Perspective. Christina Anna Cepuch, HAI Africa, Kenya.

Closing: Keynote Addresses

Summary of Key Conference Findings and Recommendations. Hans V. Hogerzeil, Formerly WHO, Switzerland.

Creating Policy Change – ICIUM messages for policy makers. Martha Gyansa-Lutterodt, Ministry of Health, Ghana.

Generating Evidence for Change – Considerations for Implementing the Post-ICIUM Research Agenda. Dennis Ross-Degnan, Harvard Medical School, United States of America.